Delivery Order SPE2DB24D2216-SPE2DB25FGNSJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Advair 500-50 Diskus inhalers (60-count units) under a firm fixed-price contract valued at $1,376.10. This non-set-aside competitive award represents a child contract issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,819.65 to AmerisourceBergen Drug Corp for the supply of Advair 500-50 Diskus 60-count inhalers on September 18, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed-price delivery order represents a direct procurement of pharmaceutical products to support federal medical supply requirements. The award was issued to AmerisourceBergen's Corporate Office located in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Advair 115 mcg 12 gm inhalers with a firm fixed price of $1,829.89. The contract is non-set-aside and competitively awarded, with performance to be completed by September 30, 2025, at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) vehicle, the DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,653.61 to AmerisourceBergen Drug Corp for the supply of Advair 250-50 Diskus inhalers (60-count units). The contract was competitively awarded without set-aside designation under firm fixed pricing terms, with an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Advair HFA 230-21 mcg inhalers (12 gm) valued at $4,403.25. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to conclude by August 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a $5,167.20 delivery order to AmerisourceBergen Drug Corp for Advair 500-50 Diskus inhalers (60-count units) on May 28, 2025, with completion scheduled for May 29, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, was selected to...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Advair 115mcg 12gm inhalers at a firm fixed price of $2,429.57, with completion scheduled for June 20, 2025. This competitively awarded, non-set-aside contract represents a child delivery order executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Advair HFA 230/21 microgram inhalers in 12-gram units, with a contract ceiling value of $1,608.05. This firm fixed-price delivery order, which is due for completion by August 29, 2025, represents a non-competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX). The pharmaceutical product will...
- The Defense Logistics Agency awarded a $2,646.36 delivery order to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm), with an ultimate completion date of June 13, 2025. This competitive award—utilizing firm fixed pricing with no set-aside designation—represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and running through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order valued at $2,618.19 to AmerisourceBergen Drug Corp for Advair HFA 230-21 mcg inhalers (12 gm) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGNSJDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $7,696.20 on May 20, 2025, for the supply of Advair 500-50 Diskus inhalers (60-count units). This firm fixed-price delivery order, with an ultimate completion date of May 21, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical prime vendor agreement with DLA Troop Support Medical. The award was competitively made with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. This delivery order for Advair falls within that broader contract framework, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 5/20/25 |